000 01138 a2200337 4500
005 20250511135827.0
264 0 _c19800426
008 198004s 0 0 eng d
022 _a0306-5251
040 _aNLM
_beng
_cNLM
100 1 _aThompson, F D
245 0 0 _aMonotherapy with labetalol for hypertensive patients with normal and impaired renal function.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_c1979
300 _a129S-133S p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCreatinine
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEthanolamines
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aKidney Diseases
_xcomplications
650 0 4 _aLabetalol
_xadverse effects
650 0 4 _aPhysical Exertion
650 0 4 _aPosture
650 0 4 _aPulse
_xdrug effects
650 0 4 _aTime Factors
700 1 _aJoekes, A M
700 1 _aHussein, M M
773 0 _tBritish journal of clinical pharmacology
_gvol. 8
_gno. Suppl 2
_gp. 129S-133S
999 _c546805
_d546805